Ganli Pharmaceutical: Ganjing Insulin Injection and its prefilled injection pen have obtained drug registration approval in Ethiopia.

Ganli Pharmaceuticals announced that recently, the company has received approval from the Ethiopian Food and Drug Administration for the registration of Ganli insulin injection and pre-filled insulin injection pen. The drug name is BasalinTM, indicated for diabetes, in injection form, with specifications of 3ml:100units/ml and 3ml:100units/ml. Ganli insulin is a long-acting basal insulin, to be injected subcutaneously once daily, with a duration of blood sugar-lowering effect for 24 hours.